Mary Kathryn Dahlgren, PhD
Assistant Neuroscientist, Cognitive and Clinical Neuroimaging Core, Marijuana Investigations for Neuroscientific Discovery (MIND)
- Instructor in Psychiatry
Dr. Mary Kathryn (Kate) Dahlgren is an assistant neuroscientist in the Cognitive and Clinical Neuroimaging Core (CCNC) and the Marijuana Investigations for Neuroscientific Discovery (MIND) program, both led by Dr. Staci Gruber. Her work focuses on the impact of both recreational and medical cannabis use on cognition, clinical state, neural activation, and brain structure. Dr. Dahlgren’s specific interests include researching vulnerability factors for developing psychological disorders, identifying predictors of treatment response, and advanced statistical analyses, particularly regression modeling.
Dr. Dahlgren was awarded the 2017 McLean Hospital Rossano Mind, Brain, and Behavior Pre-Doctoral Fellowship and the 2020 McLean Hospital Jonathan Edward Brooking Mental Health Post-Doctoral Fellowship to examine the impact of recreational and medical cannabis use on driving. Results from this research garnered international attention with coverage in The Boston Globe, Discovery Magazine, Forbes, CNN, and other news outlets.
Education & Training
- 2006 BA in Psychology and Neuroscience, Smith College
- 2015 MS in Clinical Experimental Psychology, Tufts University
- 2018 PhD in Clinical Experimental Psychology, Tufts University
- 2017-2018 Rossano Mind, Brain, and Behavior Pre-Doctoral Research Fellowship, McLean Hospital
- 2018-2021 Post-Doctoral Research Fellowship, McLean Hospital/Harvard Medical School
- 2020-2021 Jonathan Edward Brooking Mental Health Research Fellowship, McLean Hospital